| Literature DB >> 27630734 |
Beverley de Valois1, Anthea Asprey2, Teresa Young1.
Abstract
Background. Lymphoedema, a distressing consequence of cancer treatment, has significant negative impact on health-related quality of life. Multidisciplinary approaches are needed to improve physical and psychosocial wellbeing. Acupuncture and moxibustion (acu/moxa), two modalities of traditional East Asian medicine, may contribute to improved outcomes for cancer survivors with lymphoedema. Aim. To explore how patients with lymphoedema secondary to cancer treatment perceive and experience acu/moxa treatment. Design and Setting. A qualitative focus group study, nested in a 3-step mixed methods observational study, was carried out in a cancer drop-in and information centre in north-west London. Methods. Six focus groups and one telephone interview were conducted with 23 survivors of breast or head and neck cancer, who had completed up to 13 acu/moxa treatments. Scripts were transcribed, coded, and analysed to identify salient and overarching themes. Results. Participants described feeling disempowered by cancer treatment and subsequent diagnosis of lymphoedema. Acu/moxa was valued for its whole-person approach and for time spent with a practitioner who cared, listened, and responded. Participants reported changes in physical and psychosocial health, including increased energy levels and reduced pain and discomfort, and feelings of empowerment, personal control, and acceptance. Many were motivated to improve self-care. Conclusion. Many participants who received acu/moxa treatment reported improved wellbeing and a more proactive attitude towards self-care.Entities:
Year: 2016 PMID: 27630734 PMCID: PMC5007335 DOI: 10.1155/2016/4298420
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Focus group details.
| Focus group | Planned number | Actual | Gender | Cancer type | Nonattendees | Duration (minutes) |
|---|---|---|---|---|---|---|
| 1 | 4 | 4 | 1 female | 4 HNT | 0 | 62 |
| 2 | 4 | 2 | 4 female | 4 breast | 21 | 42 |
| 3 | 4 | 4 | 4 female | 4 breast | 0 | 56 |
| 4 | 5 | 4 | 5 female | 1 HNT | 12 | 51 |
| 5 | 4 | 4 | 4 female | 4 breast | 0 | 70 |
| 6 | 5 | 4 | 5 female | 1 HNT | 13 | 72 |
11 participant cancelled at short notice citing work commitments; 1 participant cancelled at short notice, explaining she felt unable to participate in a group but would like to give feedback. A telephone interview was arranged to accommodate this.
21 participant was unable to come to this group and was rescheduled to focus group 6.
31 participant felt ill and was unable to attend at short notice.
Questioning route (abridged).
| Introductory | How did you learn about this research study? |
|---|---|
| Transition | Think back to when you first became involved in the study: |
|
| |
| Key | What was it like for you actually having the treatments? |
|
| |
| Ending | What improvements could we make for a future study? |
Participant characteristics.
| Characteristic | HNC, | BC, | Total, |
|---|---|---|---|
|
| |||
| Mean [minimum–maximum] | 63.7 [50–83] | 58.5 [43–73] | 59.9 [43–83] |
|
| |||
|
| |||
| Female, | 3 [50] | 17 [100] | 20 [87] |
| Male, | 3 [50] | 0 [0] | 3 [13] |
|
| |||
|
| |||
| White | 5 [83] | 15 [88] | 20 [87] |
| Asian | 1 [17] | 2 [33] | 3 [13] |
|
| |||
|
| |||
| Less than compulsory | 2 [33] | 0 | 2 [9] |
| Compulsory | 2 [33] | 4 [23] | 6 [26] |
| Postcompulsory | 0 | 8 [47] | 8 [35] |
| University | 2 [33] | 3 [18] | 5 [22] |
| Postgraduate | 0 | 2 [12] | 2 [9] |
|
| |||
|
| |||
| Retired | 5 [83] | 6 [35] | 11 [48] |
| Not employed | 0 | 3 [18] | 3 [13] |
| Working part-time | 0 | 5 [29] | 5 [22] |
| Working full-time | 1 [17] | 3 [18] | 4 [17] |
|
| |||
|
| |||
| Mean (SD) | 60.00 (46.63) | 46.76 (31.88) | 50.22 (35.62) |
| Minimum–maximum | 6–108 | 12–132 | 6–132 |
|
| |||
|
| |||
| Mean (SD) | 74.17 (42.56) | 93.71 (81.55) | 88.61 (72.97) |
| Minimum–maximum | 16–131 | 6–278 | 6–278 |
HNC: head and neck cancer, BC: breast cancer, SD: standard deviation, and tx: treatment.
Figure 1Acu/moxa as a process for long-term healthcare.